Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The subcutaneous route allows for gradual absorption and distribution, which may help moderate peak concentrations and reduce acute toxicity compared to intravenous administration
Anywhere a single-use immediate-injection workflow applies, sterile water can substitute
The evidence base for tirzepatide as monotherapy is robust, with pivotal trials including SURMOUNT-1 demonstrating significant weight reduction in adults with obesity, and SURPASS trials establishing glycemic efficacy in type 2 diabetes
24-week continuous: Mirrors the longest human trial duration
Other reported effects include: Headaches and dizziness Nausea and gastrointestinal discomfort Allergic reactions to B12 formulations (rare) If you experience symptoms suggesting a severe allergic reaction (difficulty breathing, severe rash, swelling of face/throat), seek emergency medical attention immediately by calling 999 or attending A&E
Core Research Applications Metabolic health : Preclinical data indicate that NNMT inhibition may reduce fat cell size and support improved insulin sensitivity and glucose tolerance in diet-induced obesity models
